Overriding Drug-Drug Interaction Alerts in Clinical Decision Support Systems: A Scoping Review.
Drug interactions
Medical Order Entry Systems
Review
Journal
Studies in health technology and informatics
ISSN: 1879-8365
Titre abrégé: Stud Health Technol Inform
Pays: Netherlands
ID NLM: 9214582
Informations de publication
Date de publication:
06 Jun 2022
06 Jun 2022
Historique:
entrez:
8
6
2022
pubmed:
9
6
2022
medline:
10
6
2022
Statut:
ppublish
Résumé
Ineffective computerized alerts for potential Drug-Drug Interactions (DDI) is a longstanding informatics issue. Prescribing clinicians often ignore or override such alerts due to lack of context and clinical relevance, among various other reasons. In this study, we reveiwed published data on the rate of DDI alert overrides and medications involved in the overrides. We identified 34 eligible studies from sites across Asia, Europe, the United States, and the United Kingdom. The override rate of DDI alerts ranged from 55% to 98%, with more than half of the studies reporting the most common drug pairs or medications involved in acceptance or overriding of alerts. The high prevalance of alert overrides highlights the need for decision support systems that take user, drug, and institutional factors into consideration, as well as actionable metrics to better characterize harm associated with overrides.
Identifiants
pubmed: 35673040
pii: SHTI220101
doi: 10.3233/SHTI220101
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
380-384Subventions
Organisme : AHRQ HHS
ID : R01 HS025984
Pays : United States